D

Taysha Gene Therapies, Inc. TSHA

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.97$4.18
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue -13.07% -32.27% 3.42% 17.28% -36.36%
Total Other Revenue -- -- -- -- --
Total Revenue -13.07% -32.27% 3.42% 17.28% -36.36%
Cost of Revenue -- -- -- -- --
Gross Profit -13.07% -32.27% 3.42% 17.28% -36.36%
SG&A Expenses 38.21% 24.44% 17.85% 16.98% 20.74%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 56.70% 66.64% 53.99% 26.66% 17.36%
Operating Income -61.01% -75.62% -58.36% -27.56% -23.81%
Income Before Tax -56.14% -61.38% -49.69% -22.06% -338.82%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -56.14% -61.38% -49.69% -22.06% -338.82%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -56.14% -61.38% -49.69% -22.06% -338.82%
EBIT -61.01% -75.62% -58.36% -27.56% -23.81%
EBITDA -61.71% -76.60% -59.26% -28.08% -24.39%
EPS Basic -25.13% -23.02% -12.32% 5.18% -432.32%
Normalized Basic EPS -29.84% -35.66% -20.55% 0.50% -2,532.00%
EPS Diluted -25.13% -23.02% -12.32% 5.18% -432.32%
Normalized Diluted EPS -29.84% -35.66% -20.55% 0.50% -2,532.00%
Average Basic Shares Outstanding 26.08% 31.07% 32.45% 27.76% 26.15%
Average Diluted Shares Outstanding 26.08% 31.07% 32.45% 27.76% 26.15%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --